Earlier this month, Johnson & Johnson coronavirus vaccines were put on a hold after causing blood clots. Since this temporary pause, questions arose about the safety of this vaccine, how it compares to the Pfizer and Moderna coronavirus vaccines, and much more.
After the federal government put a pause on the Johnson & Johnson vaccine, the medical community immediately rushed to quell concerns. Health officials claimed that the blood clots following the Johnson & Johnson coronavirus vaccine are rare and not something the public should worry about.
On Friday, Americans learned that that the distribution of the Johnson & Johnson vaccine shall resume, as Breitbart News documents.
The Comeback of the Johnson & Johnson COVID Vaccine
Advisers for the Center for Disease Control and Prevention (CDC) ultimately voted in favor of bringing back the Johnson & Johnson vaccine.
According to these advisers, the risks of blood clots from this shot are outweighed by the benefits of getting vaccinated. However, the so-called “experts” did admit that younger women should be informed about the risks that the Johnson & Johnson vaccine poses, just in case they’d prefer a different brand.
Breaking: CDC vaccine advisers vote to recommend resuming use of the Johnson & Johnson coronavirus vaccine.
— Jim Sciutto (@jimsciutto) April 23, 2021
After the vote from CDC advisers, leaders announced that they would resume the distribution of the vaccine. Earlier this month, leaders and officials agreed to pause the Johnson & Johnson shot after the news of blood clots arose. As of now, however, the Johnson & Johnson vaccine is back and anyone interested in this injection can get it.
Will Americans Embrace the Johnson & Johnson Vaccine?
The return of the Johnson & Johnson vaccine doesn’t mean that everyone will eagerly roll up their sleeves. Some people will undoubtedly accept this shot without any questions; however, other folks will have reservations. Blood clots are not fun and pose a very serious threat to any individual’s health.
BREAKING: The CDC and FDA lifted the pause on Johnson & Johnson’s COVID-19 vaccine.
But unlike Pfizer and Moderna’s shots, J&J’s will likely come with a warning about the potential risk of rare blood clots.@NikkiBattiste has the latest https://t.co/lAN3wGgJNa pic.twitter.com/3Z2QTgEfWN
— CBS Evening News (@CBSEveningNews) April 24, 2021
Many Americans have pointed out that none of the coronavirus vaccines are formally approved by the Food and Drug Administration (FDA). Others expressed views that Americans getting the vaccine are being experimented upon by the healthcare community since these shots are in such early stages.
Going forward, people will likely be a bit more leery about the Johnson & Johnson COVID-19 vaccine even if they’re more trustful of Pfizer and Moderna.
What do you think about Johnson & Johnson’s coronavirus vaccine being returned to market despite its risk of causing blood clots? Would you be willing to receive the Johnson & Johnson injection? Share your perspectives with us down below in the comments section.
